Brenda M. Simon

Thomas Jefferson School of Law

Associate Professor

1155 Island Ave

San Diego, CA 92101

United States

Stanford Law School - Center for Law & the Biosciences

Non-Resident Fellow

559 Nathan Abbott Way

Stanford, CA 94305-8610

United States

SCHOLARLY PAPERS

8

DOWNLOADS
Rank 35,323

SSRN RANKINGS

Top 35,323

in Total Papers Downloads

927

CITATIONS

1

Scholarly Papers (8)

1.

Patent Cover-Up

Houston Law Review, Vol. 47, No. 5, p. 1299, 2011, Thomas Jefferson School of Law Research Paper No. 1599893
Number of pages: 58 Posted: 08 May 2010 Last Revised: 01 Feb 2014
Brenda M. Simon
Thomas Jefferson School of Law
Downloads 214 (111,782)

Abstract:

patent, defense, exception, innovation, testing, information, privacy, genetic testing, agricultural biotechnology, misuse, exhaustion

2.

How to Get a Fair Share: IP Policies for Publicly Supported Biobanks

Stanford Journal of Law, Science & Policy, May 2009, Thomas Jefferson School of Law Research Paper No. How to Get a Fair Share: IP Policies for Publicly Supported Biobanks
Number of pages: 15 Posted: 13 Aug 2009
Brenda M. Simon
Thomas Jefferson School of Law
Downloads 190 (125,158)

Abstract:

biobank, experimental use, data sharing, data access, benefit sharing, patents, genes, population studies, ethics

3.

The Implications of Technological Advancement for Obviousness

Michigan Telecommunications and Technology Law Review, Vol. 19, p. 331 (2013), Thomas Jefferson School of Law Research Paper No. 2152123
Number of pages: 47 Posted: 25 Sep 2012 Last Revised: 19 May 2016
Brenda M. Simon
Thomas Jefferson School of Law
Downloads 153 (128,942)

Abstract:

intellectual property, patent, creativity, nonobviousness, science, invention

4.

Rules, Standards, and the Reality of Obviousness

Case Western Law Review, Vol. 65, p. 25, 2014, Thomas Jefferson School of Law Research Paper No. 2447141
Number of pages: 37 Posted: 08 Jun 2014 Last Revised: 23 Aug 2016
Brenda M. Simon
Thomas Jefferson School of Law
Downloads 89 (194,062)

Abstract:

patent, obvious, obviousness, nonobvious, invention, technology, analogous art

5.

Pluripotent Patents Make Prime Time: An Analysis of the Emerging Landscape

Nature Biotechnology, Vol. 28, No. 6, pp. 557-559, June 2010 , Thomas Jefferson School of Law Research Paper No. 1622556
Number of pages: 3 Posted: 15 Jul 2010 Last Revised: 19 May 2016
Thomas Jefferson School of Law, University of Alberta and Baylor College of Medicine - Center for Medical Ethics and Health Policy
Downloads 30 (359,036)
Citation 1

Abstract:

Patents, pluripotency, stem cells

6.

Unsettled Expectations: How Recent Patent Decisions Affect Biotech

Nature Biotechnology, Vol. 29, No. 3, pp. 229-230, March 2011, Thomas Jefferson School of Law Research Paper No. 1792985
Number of pages: 2 Posted: 27 Mar 2011 Last Revised: 19 May 2016
Brenda M. Simon and Christopher Thomas Scott
Thomas Jefferson School of Law and Baylor College of Medicine - Center for Medical Ethics and Health Policy
Downloads 29 (348,620)

Abstract:

patent, biotechnology, validity, obviousness, eligibility, Bilski, myriad, stem cells

7.

The Pathologies of Data-Generating Patents

BIG DATA, HEALTH LAW, AND BIOETHICS (I. Glenn Cohen et al., eds., 2017 Forthcoming) , San Diego Legal Studies Paper No. 17-241, Thomas Jefferson School of Law Research Paper No. 2882459
Number of pages: 15 Posted: 13 Dec 2016 Last Revised: 26 Jan 2017
Ted M. Sichelman and Brenda M. Simon
University of San Diego School of Law and Thomas Jefferson School of Law
Downloads 0 (404,853)

Abstract:

patents, trade secrets, big data, medical diagnostic tests, biotechnology, biomedical, Myriad

8.

Data-Generating Patents

Northwestern University Law Review, Vol. 111, 2017 Forthcoming, San Diego Legal Studies Paper No. 16-216, Thomas Jefferson School of Law Research Paper No. 2753547
Number of pages: 63 Posted: 24 Mar 2016 Last Revised: 24 Aug 2016
Brenda M. Simon and Ted M. Sichelman
Thomas Jefferson School of Law and University of San Diego School of Law
Downloads 0 (178,733)

Abstract:

patents, trade secrets, big data, medical diagnostic tests, search engines, Myriad, Google